Oura’s postponement of its planned September 2026 Nasdaq IPO, which targeted a $15.6 billion fully diluted valuation at the $40–$44 share range, remains the dominant factor anchoring trader consensus at 96% odds against any listing before January 2027. Despite 3–4x oversubscribed demand and $400 million in cornerstone commitments, the company cited elevated Treasury yields, shifting Fed policy expectations, and broader market volatility as reasons to delay, noting its profitability and projected 90% revenue growth for fiscal 2026 provide flexibility. With no new SEC filings or roadshow activity evident into mid-November and the firm executing an unrelated $625 million acquisition, implied probabilities reflect limited near-term catalysts. A sustained rally in growth equities or accelerated recurring-revenue momentum could reopen the window, though timing risks persist around year-end lockup and macroeconomic data.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano1H6H1D7D30DALL
View resolved

Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania